On February 2, 2019, I sent a member alert that we were buying Blueberries Medical Corp. (BBM) for our model portfolio.
I knew this rare play on the high-growth Colombian cannabis industry would be a highly speculative trade, but I believed that we’d see a move towards the upside.
We entered BBM at $0.41. The stock continued to explode up the chart.
On March 25th, 2019, I closed the BBM trade in our model portfolio at $0.79 for a 92% gain and sent members a sell alert.
I still think Blueberries Medical Corp. is a strong stock, but I felt like quick run-up was a great time to capture profits and wait until a new buy opportunity presented itself.
About the Author
Michael Vodicka is an equity analyst with more than 20 years of experience trading and investing. His research has been featured in some of the industry’s most respected publications. He has been investing and leading investors in the cannabis sector since 2013.